Childhood Exposure to Bacterial Toxin May Be Triggering Colorectal Cancer Epidemic Among the Young Apr. 23, 2025 — An international team has identified a potential microbial culprit behind the ...

Learn more about colon cancer during an outreach event presented by the OHSU Knight Cancer Institute and Columbia River ...

A blood test intended to detect colorectal cancer performed well in a clinical study, a step towards expanding options for screening the potentially deadly disease. Published in the New England ...

Colorectal cancer is increasingly affecting younger individuals, including those in their 20s and 30s. Recent studies have shown a significant rise in early-onset colorectal cancer (EOCC ...

Colon cancer is the third most common cancer in males Oral cavity bacteria are responsible for the progression of colon cancer Adopting a healthy diet and habits may help lower your colorectal ...

This colorized abdominal X-ray shows cancer of the ascending colon; the tumor appears as the oval shadow over the right pelvic bone (left on image). Colorectal cancer is often thought to ...

Colorectal cancer is the third most diagnosed type of cancer worldwide. Up to 80% of the cases are related to environmental factors and lifestyle, such as poor diet, sedentarism, obesity ...

As scientists question the rise in early colon cancer cases, a new study is offering some potential answers. Colored scanning electron micrograph (SEM) of a macrophage white blood cell (center ...

Two years ago, Emma Dimery was told her stage 4 colon cancer was incurable. Today, she is healthy and cancer-free — and she says a last-resort clinical trial saved her life. Dimery, who lives in ...

Researchers are investigating whether a widely used diabetes medication could aid in the fight against colorectal cancer after the disease strikes. Scientists are cautiously optimistic that this ...

Colorectal cancer diagnoses among younger people have skyrocketed in recent years. A staggering 20% of cases in 2019 were in people younger than 55, up from 11% in 1995. The trend is particularly ...

CX-2051 demonstrated a 28% overall response rate in advanced colorectal cancer, with a 43% response at the highest dose of 10 mg/kg. The disease control rate was 94%, and median progression-free ...